Page last updated: 2024-08-17

diethylnitrosamine and fosbretabulin

diethylnitrosamine has been researched along with fosbretabulin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alghzzawy, ZM; Awwad, MH; El-Hamid Hagag, SA; Elmaghraby, TK	1

Other Studies

1 other study(ies) available for diethylnitrosamine and fosbretabulin

Article	Year
Combretastatin A-4 disodium phosphate and low dose gamma irradiation suppress hepatocellular carcinoma by downregulating ROCK1 and VEGF gene expression. Molecular biology reports, 2020, Volume: 47, Issue:3 Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Chemoradiotherapy; Combined Modality Therapy; Diethylnitrosamine; Down-Regulation; Egypt; Gamma Rays; Gene Expression Regulation, Neoplastic; Liver Neoplasms; Male; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Wistar; rho-Associated Kinases; Stilbenes; Treatment Outcome; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2020

Article

Year

Combretastatin A-4 disodium phosphate and low dose gamma irradiation suppress hepatocellular carcinoma by downregulating ROCK1 and VEGF gene expression.

Molecular biology reports, 2020, Volume: 47, Issue:3

Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Chemoradiotherapy; Combined Modality Therapy; Diethylnitrosamine; Down-Regulation; Egypt; Gamma Rays; Gene Expression Regulation, Neoplastic; Liver Neoplasms; Male; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Wistar; rho-Associated Kinases; Stilbenes; Treatment Outcome; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2020